Discounted Cash Flow Rating
Buy
Return on Equity Rating
Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Sell
Analyst Rating
Neutral
Simple Moving Average
Buy
Exponential Moving Average
Buy
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Buy
A
Anika Therapeutics Inc (ANIK)
Surgical & Medical Instruments & Apparatus
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
32 WIGGINS AVENUE
BEDFORD, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
05/03/1993
Market Cap
377,315,850
Shares Outstanding
14,640,000
Weighted SO
14,640,886
Total Employees
N/A
Upcoming Earnings
08/13/2024
Beta
0.8270
Last Div
0.0000
Range
16.54-29.12
Chg
-0.0400
Avg Vol
48775
Mkt Cap
377315850
Exch
NASDAQ
Country
US
Phone
781 457 9000
DCF Diff
2.6081
DCF
22.8919
Div Yield
0.0000
P/S
2.2610
EV Multiple
-57.8763
P/FV
1.7990
Div Yield %
0.0000
P/E
-5.1012
PEG
-0.5166
Payout
0.0000
Current Ratio
5.9339
Quick Ratio
3.9637
Cash Ratio
2.4050
DSO
73.8683
DIO
295.2866
Op Cycle
369.1549
DPO
57.3429
CCC
311.8120
Gross Margin
0.6188
Op Margin
-0.0849
Pretax Margin
-0.4432
Net Margin
-0.4445
Eff Tax Rate
-0.0030
ROA
-0.2824
ROE
-0.3291
ROCE
-0.0599
NI/EBT
1.0030
EBT/EBIT
5.2204
EBIT/Rev
-0.0849
Debt Ratio
0.1069
D/E
0.1335
LT Debt/Cap
0.1092
Total Debt/Cap
0.1178
Int Coverage
-7.8531
CF/Debt
0.3180
Equity Multi
1.2487
Rec Turnover
4.9412
Pay Turnover
6.3652
Inv Turnover
1.2361
FA Turnover
2.2118
Asset Turnover
0.6354
OCF/Share
0.6017
FCF/Share
0.0766
Cash/Share
4.2336
OCF/Sales
0.0535
FCF/OCF
0.1272
CF Coverage
0.3180
ST Coverage
3.9038
CapEx Coverage
1.1458
Div&CapEx Cov
1.1458
P/BV
1.7990
P/B
1.7990
P/S
2.2610
P/E
-5.1012
P/FCF
332.1442
P/OCF
42.3829
P/CF
42.3829
PEG
-0.5166
P/S
2.2610
EV Multiple
-57.8763
P/FV
1.7990
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
570.66K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
3 - 6 Months
106.35K Shares Bought (42.04 %)
146.62K Shares Sold (57.96%)
6 - 9 Months
2.49K Shares Bought (43.59 %)
3.22K Shares Sold (56.41%)
9 - 12 Months
49.36K Shares Bought (48.63 %)
52.14K Shares Sold (51.37 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 26.96M | ▲ 29.77M | ▲ 32.69M | ▲ 35.82M | ▲ 39.62M | ▲ 42.97M | ▼ 40.52M |
Cost Of Revenue | 7.00M | ▲ 8.65M | ▲ 15.94M | ▲ 17.69M | ▼ 15.49M | ▲ 16.64M | ▼ 15.90M |
Gross Profit | 19.96M | ▲ 21.12M | ▼ 16.75M | ▲ 18.13M | ▲ 24.13M | ▲ 26.33M | ▼ 24.63M |
Gross Profit Ratio | 0.74 | ▼ 0.71 | ▼ 0.51 | ▼ 0.51 | ▲ 0.61 | ▲ 0.61 | ▼ 0.61 |
Research And Development Expenses | 4.06M | ▲ 4.08M | ▲ 7.63M | ▼ 6.00M | ▲ 7.75M | ▼ 7.59M | ▲ 8.16M |
General And Administrative Expenses | 6.13M | ▲ 12.24M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling General And Administrative Expenses | 6.13M | ▲ 12.24M | ▲ 15.18M | ▲ 20.43M | ▲ 23.05M | ▼ 20.34M | ▲ 21.53M |
Other Expenses | 31.28M | ▼ 28.75M | ▼ 13.85M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 10.19M | ▲ 16.32M | ▲ 22.81M | ▲ 26.43M | ▲ 30.80M | ▼ 27.92M | ▲ 29.69M |
Cost And Expenses | 17.19M | ▲ 24.97M | ▲ 38.75M | ▲ 44.12M | ▲ 46.29M | ▼ 44.56M | ▲ 45.59M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 276.00K | ▲ 577.00K | ▼ 0.00 |
Interest Expense | -551.00K | ▲ -360.00K | ▲ -184.00K | ▲ -47.00K | ▲ 276.00K | ▲ 1.21M | ▼ 592.00K |
Depreciation And Amortization | 1.48M | ▲ 1.53M | ▲ 3.50M | ▲ 3.73M | ▼ 3.67M | ▼ 3.59M | ▼ 2.60M |
Ebitda | 9.76M | ▼ 4.80M | ▲ 5.82M | ▼ -7.47M | ▲ -6.67M | ▲ 2.00M | ▼ -2.46M |
Ebitda Ratio | 0.36 | ▼ 0.16 | ▲ 0.18 | ▼ -0.21 | ▲ -0.17 | ▲ 0.05 | ▼ -0.06 |
Operating Income | 9.76M | ▼ 4.80M | ▼ -17.95M | ▲ -9.12M | ▲ -6.67M | ▲ -1.59M | ▼ -5.06M |
Operating Income Ratio | 0.36 | ▼ 0.16 | ▼ -0.55 | ▲ -0.25 | ▲ -0.17 | ▲ -0.04 | ▼ -0.12 |
Total Other Income Expenses Net | 551.00K | ▼ 360.00K | ▼ -11.89M | ▲ -825.00K | ▲ 276.00K | ▼ -61.61M | ▲ 592.00K |
Income Before Tax | 10.31M | ▼ 5.16M | ▼ -18.14M | ▲ -9.17M | ▲ -6.39M | ▼ -63.20M | ▲ -4.47M |
Income Before Tax Ratio | 0.38 | ▼ 0.17 | ▼ -0.55 | ▲ -0.26 | ▲ -0.16 | ▼ -1.47 | ▲ -0.11 |
Income Tax Expense | 2.60M | ▼ 1.11M | ▼ -2.48M | ▼ -3.38M | ▲ -1.48M | ▲ -204.00K | ▲ 43.00K |
Net Income | 7.72M | ▼ 4.05M | ▼ -15.66M | ▲ -5.79M | ▲ -4.91M | ▼ -63.00M | ▲ -4.51M |
Net Income Ratio | 0.29 | ▼ 0.14 | ▼ -0.48 | ▲ -0.16 | ▲ -0.12 | ▼ -1.47 | ▲ -0.11 |
Eps | 0.54 | ▼ 0.28 | ▼ -1.10 | ▲ -0.40 | ▲ -0.34 | ▼ -4.30 | ▲ -0.31 |
Eps Diluted | 0.54 | ▼ 0.28 | ▼ -1.10 | ▲ -0.40 | ▲ -0.34 | ▼ -4.30 | ▲ -0.31 |
Weighted Average Shs Out | 14.17M | ▲ 14.28M | ▼ 14.28M | ▲ 14.37M | ▲ 14.64M | ▲ 14.65M | ▲ 14.70M |
Weighted Average Shs Out Dil | 14.30M | ▲ 14.62M | ▼ 14.28M | ▲ 14.44M | ▲ 14.64M | ▲ 14.65M | ▲ 14.70M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 89.04M | ▲ 157.46M | ▼ 95.82M | ▼ 94.39M | ▼ 86.33M | ▼ 72.87M | ▼ 68.63M |
Short Term Investments | 69.97M | ▼ 27.48M | ▼ 2.50M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 159.01M | ▲ 184.94M | ▼ 98.32M | ▼ 94.39M | ▼ 86.33M | ▼ 72.87M | ▼ 68.63M |
Net Receivables | 20.78M | ▲ 23.08M | ▲ 24.10M | ▲ 29.84M | ▲ 34.63M | ▲ 35.96M | ▼ 32.08M |
Inventory | 21.30M | ▲ 22.00M | ▲ 46.21M | ▼ 36.01M | ▲ 39.77M | ▲ 46.39M | ▲ 49.41M |
Other Current Assets | 1.85M | ▼ 1.44M | ▲ 8.75M | ▼ 8.29M | ▲ 8.83M | ▼ 8.10M | ▲ 8.85M |
Total Current Assets | 202.94M | ▲ 235.75M | ▼ 177.38M | ▼ 168.53M | ▲ 169.55M | ▼ 163.31M | ▼ 158.96M |
Property Plant Equipment Net | 54.11M | ▲ 73.65M | ▼ 73.23M | ▼ 68.56M | ▲ 78.98M | ▼ 74.97M | ▼ 74.24M |
Goodwill | 7.85M | ▼ 7.69M | ▲ 8.41M | ▼ 7.78M | ▼ 7.34M | ▲ 7.57M | ▼ 7.40M |
Intangible Assets | 9.19M | ▼ 7.59M | ▲ 91.16M | ▼ 82.38M | ▼ 74.60M | ▼ 4.63M | ▼ 4.30M |
Goodwill And Intangible Assets | 17.04M | ▼ 15.28M | ▲ 99.57M | ▼ 90.16M | ▼ 81.94M | ▼ 12.20M | ▼ 11.70M |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 4.63M | ▼ 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.45M | ▲ 1.49M | ▼ 1.27M |
Other Non Current Assets | 4.90M | ▲ 7.48M | ▲ 15.42M | ▲ 20.29M | ▼ 17.22M | ▼ 14.05M | ▲ 17.57M |
Total Non Current Assets | 76.05M | ▲ 96.40M | ▲ 188.22M | ▼ 179.01M | ▲ 179.58M | ▼ 107.32M | ▼ 104.78M |
Other Assets | 0.00 | ▼ -1.44M | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 278.99M | ▲ 330.71M | ▲ 365.61M | ▼ 347.54M | ▲ 349.13M | ▼ 270.63M | ▼ 263.74M |
Account Payables | 3.14M | ▲ 3.83M | ▲ 8.98M | ▼ 7.63M | ▲ 9.07M | ▲ 9.86M | ▲ 10.02M |
Short Term Debt | 0.00 | ▲ 1.14M | ▲ 1.59M | ▲ 1.71M | ▲ 2.07M | ▲ 2.13M | ▼ 2.13M |
Tax Payables | 385.00K | ▼ 0.00 | 0.00 | 0.00 | ▲ 810.00K | ▲ 1.24M | ▲ 1.49M |
Deferred Revenue | 0.00 | 0.00 | ▲ 13.21M | ▲ 16.13M | ▼ 0.00 | ▲ 1.24M | ▲ 1.49M |
Other Current Liabilities | 8.15M | ▲ 11.30M | ▲ 13.09M | ▼ 4.32M | ▲ 16.77M | ▲ 17.83M | ▼ 14.82M |
Total Current Liabilities | 11.29M | ▲ 16.28M | ▲ 36.87M | ▼ 29.80M | ▼ 27.91M | ▲ 31.06M | ▼ 28.46M |
Long Term Debt | 0.00 | ▲ 21.37M | ▼ 20.88M | ▼ 19.24M | ▲ 28.82M | ▼ 26.90M | ▼ 26.34M |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -15.70M | ▲ 0.00 |
Deferred Tax Liabilities Non Current | 3.54M | ▲ 4.33M | ▲ 11.90M | ▼ 10.16M | ▼ 6.44M | ▲ 15.70M | ▼ 0.00 |
Other Non Current Liabilities | 550.00K | ▼ 357.00K | ▲ 23.56M | ▼ 1.26M | ▼ 398.00K | ▲ 404.00K | 404.00K |
Total Non Current Liabilities | 4.09M | ▲ 26.06M | ▲ 56.34M | ▼ 30.66M | ▲ 35.65M | ▼ 27.31M | ▼ 26.75M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | 1.00 |
Capital Lease Obligations | 0.00 | ▲ 21.37M | ▼ 20.88M | ▼ 19.24M | ▲ 28.82M | ▼ 26.90M | ▼ 26.34M |
Total Liabilities | 15.38M | ▲ 42.33M | ▲ 93.21M | ▼ 60.45M | ▲ 63.57M | ▼ 58.37M | ▼ 55.21M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 142.00K | ▲ 143.00K | 143.00K | ▲ 144.00K | ▲ 146.00K | ▲ 147.00K | ▲ 148.00K |
Retained Earnings | 218.23M | ▲ 245.43M | ▼ 221.44M | ▲ 225.58M | ▼ 210.72M | ▼ 128.05M | ▼ 123.54M |
Accumulated Other Comprehensive Income Loss | -5.53M | ▼ -5.90M | ▲ -4.54M | ▼ -5.72M | ▼ -6.44M | ▲ -5.94M | ▼ -6.32M |
Other Total Stockholders Equity | 50.76M | ▼ 48.71M | ▲ 55.36M | ▲ 67.08M | ▲ 81.14M | ▲ 90.01M | ▲ 91.17M |
Total Stockholders Equity | 263.61M | ▲ 288.38M | ▼ 272.40M | ▲ 287.09M | ▼ 285.56M | ▼ 212.27M | ▼ 208.54M |
Total Equity | 263.61M | ▲ 288.38M | ▼ 272.40M | ▲ 287.09M | ▼ 285.56M | ▼ 212.27M | ▼ 208.54M |
Total Liabilities And Stockholders Equity | 278.99M | ▲ 330.71M | ▲ 365.61M | ▼ 347.54M | ▲ 349.13M | ▼ 270.63M | ▼ 263.74M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 278.99M | ▲ 330.71M | ▲ 365.61M | ▼ 347.54M | ▲ 349.13M | ▼ 270.63M | ▼ 263.74M |
Total Investments | 69.97M | ▼ 27.48M | ▼ 2.50M | ▼ 0.00 | 0.00 | ▲ 4.63M | ▼ 0.00 |
Total Debt | 0.00 | ▲ 21.37M | ▼ 20.88M | ▼ 19.24M | ▲ 30.89M | ▼ 29.04M | ▼ 28.47M |
Net Debt | -89.04M | ▼ -136.10M | ▲ -74.94M | ▼ -75.15M | ▲ -55.44M | ▲ -43.83M | ▲ -40.16M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | 7.72M | ▼ 4.05M | ▼ -15.66M | ▲ -5.79M | ▲ -4.91M | ▼ -63.00M | ▲ -4.51M |
Depreciation And Amortization | 1.48M | ▲ 1.53M | ▲ 3.50M | ▲ 3.73M | ▼ 3.67M | ▼ 3.59M | ▼ 2.60M |
Deferred Income Tax | -612.00K | ▲ -147.00K | ▼ -241.00K | ▼ -2.78M | ▲ -1.78M | ▼ -1.84M | ▲ 193.00K |
Stock Based Compensation | 982.00K | ▲ 1.95M | ▼ 1.43M | ▲ 3.17M | ▲ 3.81M | ▲ 3.82M | ▼ 3.59M |
Change In Working Capital | 349.00K | ▲ 3.70M | ▼ -6.13M | ▲ 904.00K | ▼ -2.47M | ▼ -2.61M | ▼ -4.18M |
Accounts Receivables | -222.00K | ▲ 912.00K | ▼ -1.96M | ▲ 2.11M | ▼ -647.00K | ▼ -1.10M | ▲ 3.62M |
Inventory | -1.69M | ▲ 1.02M | ▼ -5.34M | ▲ 498.00K | ▼ -2.94M | ▼ -3.14M | ▼ -4.09M |
Accounts Payables | 778.00K | ▲ 1.10M | ▲ 2.73M | ▼ -398.00K | ▲ 1.43M | ▼ 1.31M | ▼ 401.00K |
Other Working Capital | 1.48M | ▼ 674.00K | ▼ -1.57M | ▲ -1.30M | ▲ -311.00K | ▲ 324.00K | ▼ -4.11M |
Other Non Cash Items | 99.00K | ▲ 1.94M | ▲ 19.68M | ▼ 5.25M | ▼ 2.16M | ▲ 63.69M | ▼ 11.04M |
Net Cash Provided By Operating Activities | 10.01M | ▲ 13.02M | ▼ 2.59M | ▲ 4.47M | ▼ 481.00K | ▲ 3.64M | ▼ -126.00K |
Investments In Property Plant And Equipment | -163.00K | ▼ -268.00K | ▼ -449.00K | ▼ -1.13M | ▼ -2.53M | ▲ -1.84M | ▲ -1.81M |
Acquisitions Net | 0.00 | 0.00 | ▼ -742.00K | ▲ -113.00K | ▲ 0.00 | 0.00 | 0.00 |
Purchases Of Investments | -13.92M | ▼ -17.48M | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sales Maturities Of Investments | 11.50M | ▲ 58.77M | ▼ 18.00M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash Used For Investing Activities | -2.58M | ▲ 41.02M | ▼ 16.81M | ▼ -1.24M | ▼ -2.53M | ▲ -1.84M | ▲ -1.81M |
Debt Repayment | 0.00 | 0.00 | ▼ -25.05M | ▲ -9.00K | ▲ 0.00 | 0.00 | 0.00 |
Common Stock Issued | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 666.00K | ▼ 335.00K | ▼ 23.00K |
Common Stock Repurchased | -30.00M | -30.00M | ▲ 0.00 | 0.00 | ▲ 1.00K | ▲ 7.00K | ▼ -2.30M |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 29.95M | ▲ 30.28M | ▼ -3.06M | ▲ 69.00K | ▼ 1.00K | ▲ 7.00K | ▼ -2.30M |
Net Cash Used Provided By Financing Activities | -55.00K | ▲ 278.00K | ▼ -28.11M | ▲ 60.00K | ▲ 667.00K | ▼ 342.00K | ▼ -2.27M |
Effect Of Forex Changes On Cash | -160.00K | ▼ -242.00K | ▲ 317.00K | ▼ 118.00K | ▼ -69.00K | ▲ 76.00K | ▼ -31.00K |
Net Change In Cash | 7.22M | ▲ 54.08M | ▼ -8.40M | ▲ 3.41M | ▼ -1.45M | ▲ 2.22M | ▼ -4.24M |
Cash At End Of Period | 89.04M | ▲ 157.46M | ▼ 95.82M | ▼ 94.39M | ▼ 86.33M | ▼ 72.87M | ▼ 68.63M |
Cash At Beginning Of Period | 81.83M | ▲ 103.38M | ▲ 104.22M | ▼ 90.98M | ▼ 87.78M | ▼ 70.65M | ▲ 72.87M |
Operating Cash Flow | 10.01M | ▲ 13.02M | ▼ 2.59M | ▲ 4.47M | ▼ 481.00K | ▲ 3.64M | ▼ -126.00K |
Capital Expenditure | -163.00K | ▼ -268.00K | ▼ -449.00K | ▼ -1.13M | ▼ -2.53M | ▲ -1.84M | ▲ -1.81M |
Free Cash Flow | 9.85M | ▲ 12.75M | ▼ 2.14M | ▲ 3.35M | ▼ -2.05M | ▲ 1.80M | ▼ -1.93M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)